Cantor Fitzgerald Reiterates Overweight on IREN, Maintains $99 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.3%

Neg 0% Neu 85.3% Pos 0%

Cantor Fitzgerald analyst Brett Knoblauch reiterates IREN (NASDAQ:IREN) with a Overweight and maintains $99 price target.